RWJBarnabas outlook revised to negative

Reduced cash flow and an ongoing need to fund capital expenditure projects has resulted in an outlook revision to negative for West Orange, N.J.-based RWJBarnabas Health, Moody’s said July 25.

Advertisement

The system, which includes 12 acute-care hospitals, had an “Aa3” rating affirmed on approximately $3.3 billion of debt. 

“The revision of the outlook to negative from stable reflects challenges RWJBH will face in restoring cash flow and likely further dilution of days cash and cash to total debt metrics in light of planned capital spend,” Moody’s said in the note.

As well as the acute-care hospitals, RWJBarnabas operates three acute-care children’s hospitals, a pediatric rehabilitation hospital and several outpatient facilities. The system had $7.6 billion in revenues in fiscal 2022, Moody’s said.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.